Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Modified charlson comorbidity index in predicting early mortality after liver transplantation

M Wasilewicz, J Raszeja-Wyszomirska, M Wójcicki, P Milkiewicz

Ann Transplant 2009; 14(1): 39-40 :: ID: 880341


Background: Charlson Co morbidity Index-Orthotopic LT (CCI-OLT) is a modified clinical score recently found to be useful in the assessment of a long term survival after liver transplantation (LTx) (Volk et al. Liver Transplantation 2007). It includes 9 most important associated conditions selected in multivariate analysis on a large cohort of transplanted patients. Its role in predicting early mortality after LTx has not yet been investigated. Aim: Evaluation of CCI-OLT as a potential predictor of one-month mortality after LTx.
Material/Methods: A group of 169 consecutive patients (103 males and 67 females, median age in both groups 51 years) who received their elective LTx at our centre was analysed. Patients transplanted for fulminant hepatic failure were excluded from the analysis. Viral (39%) and alcohol induced (23%) cirrhosis were most common indications for LTx. CCI-OLT index was assessed in all patients. Statistical analysis was performed with StatView Program.
Results: 146 (86%) subjects survived and 23 (14%) died within 1 month after
LTx. Fifty one (30%) patients suffered from at least 1 co-morbidity included in CCI-OLT index, a number significantly lower than in population studied by Volk et al. Direct comparison of the groups of survivors and non-survivors showed no significant difference in terms of the total frequency of co-morbidities (30.1% vs. 30.4%, p>0.99), their number and type. The most common associated condition in both groups was diabetes mellitus.
Conclusions: Contrary to the long term survival, CCI-OLT does not seem to have a role as a predictor of early (one-month) mortality after LTx.

Keywords: Liver Transplantation

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358